SCHEMBL24723975

SCHEMBL24723975

CC(C)[C@H]1C(=O)C(C)N1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
ABCB1 P08183 1/20 0.35
PREP P48147 3/20 0.33
KLK7 P49862 1/20 0.32
KLK5 Q9Y337 1/20 0.32
MAPT P10636 2/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PLA2G10 O15496 1/20 0.32
PLA2G5 P39877 1/20 0.32
GPR119 Q8TDV5 1/20 0.32
HSD11B1 P28845 1/20 0.32
KDM4E B2RXH2 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24723669 0.82 CHRM2 (0.46) CHRM2CHRM1CHRM3ABCB1PREP
SCHEMBL24723670 0.82 CHRM2 (0.46) CHRM2CHRM1CHRM3ABCB1PREP
SCHEMBL29023079 0.75 CHRM2 (0.33) CHRM2CHRM1CHRM3ABCB1
SCHEMBL16592214 0.73 CHRM2 (0.36) CHRM2CHRM1CHRM3ABCB1PREP
SCHEMBL23701497 0.72 KMT2A (0.36) CHRM2CHRM1CHRM3ABCB1MAPT
SCHEMBL647544 0.72 CHRM2 (0.41) CHRM2CHRM1CHRM3ABCB1PREP
SCHEMBL2915087 0.72 CHRM2 (0.45) CHRM2CHRM1CHRM3PREPMAPT
SCHEMBL28713687 0.72 CHRM2 (0.51) CHRM2CHRM1CHRM3ABCB1PREP
SCHEMBL13609108 0.71 CHRM2 (0.44) CHRM2CHRM1CHRM3PREPMAPT
SCHEMBL4077655 0.71 CHRM2 (0.44) CHRM2CHRM1CHRM3PREPMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388980-A1 QUINOLINE INHIBITORS OF RAD52 AND METHODS OF USE UNIV DREXEL (US) 2022-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388980-A1 QUINOLINE INHIBITORS OF RAD52 AND METHODS OF USE RAD52, RECQL, RAD50 CHRM2 2273/4885CHRM1 2962/4885CHRM3 3609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.